Should Women Who Use Drugs During Pregnancy Be Arrested and Jailed? (OpenStax Psychology 2e)
As you now know, women who use drugs or alcohol during pregnancy can cause serious lifelong harm to their child. Some people have advocated mandatory screenings for women who are pregnant and have a history of drug abuse, and if the women continue using, to arrest, prosecute, and incarcerate them (Figdor & Kaeser, 1998). This policy was tried in Charleston, South Carolina, as recently as 20 years ago. The policy was called the Interagency Policy on Management of Substance Abuse During Pregnancy, and had disastrous results.
The Interagency Policy applied to patients attending the obstetrics clinic at MUSC, which primarily serves patients who are indigent or on Medicaid. It did not apply to private obstetrical patients. The policy required patient education about the harmful effects of substance abuse during pregnancy. . . . [A] statement also warned patients that protection of unborn and newborn children from the harms of illegal drug abuse could involve the Charleston police, the Solicitor of the Ninth Judicial Court, and the Protective Services Division of the Department of Social Services (DSS). (Jos, Marshall, & Perlmutter, 1995, pp. 120–121)
This policy seemed to deter women from seeking prenatal care, deterred them from seeking other social services, and was applied solely to low-income women, resulting in lawsuits. The program was canceled after 5 years, during which 42 women were arrested. A federal agency later determined that the program involved human experimentation without the approval and oversight of an institutional review board (IRB). What were the flaws in the program and how would you correct them? What are the ethical implications of charging pregnant women with child abuse?
Spielman, R. M., Jenkins, W. J., & Lovett, M. D. (2020). Psychology 2e. OpenStax. Houston, Texas. Accessed for free at https://openstax.org/details/books/psychology-2e
Research Article: Pregnancy Exposure Registries for Assessing Antimalarial Drug Safety in Pregnancy in Malaria-Endemic Countries
Date Published: September 9, 2008 Publisher: Public Library of Science Author(s): Stephanie Dellicour, Feiko O ter Kuile, Andy Stergachis Abstract: Feiko ter Kuile and colleagues argue that there is an urgent need to develop targeted pharmacovigilance systems to assess the safety of antimalarials in early pregnancy. Partial Text: Because pregnant women are routinely excluded from … Continue reading
Research Article: Relation of in-utero exposure to antiepileptic drugs to pregnancy duration and size at birth
Date Published: August 5, 2019 Publisher: Public Library of Science Author(s): Andrea V. Margulis, Sonia Hernandez-Diaz, Thomas McElrath, Kenneth J. Rothman, Estel Plana, Catarina Almqvist, Brian M. D’Onofrio, Anna Sara Oberg, Umberto Simeoni. http://doi.org/10.1371/journal.pone.0214180 Abstract: The associations of individual antiepileptic drugs (AEDs) with pregnancy duration and size at birth, and potential dose relations, are not … Continue reading
Research Article: Correction: Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition
Date Published: January 16, 2018 Publisher: Public Library of Science Author(s): Andreas Austgulen Westin, Malin Brekke, Espen Molden, Eirik Skogvoll, Olav Spigset. http://doi.org/10.1371/journal.pone.0191508 Abstract: Partial Text Source: http://doi.org/10.1371/journal.pone.0191508